isn't that exactly what article is saying? > Bluebird Bio, once a leader with three FDA-approved gene therapies, sold itself to private equity for around $30 m

isn't that exactly what article is saying? > Bluebird Bio, once a leader with three FDA-approved gene therapies, sold itself to private equity for around $30 million earlier this year, a 99.7% decline from their all-time-high $10b valuation *investment* is there, market isn't